Aims and Scope
==============

*Cancer Medicine* is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences. The journal considers submissions from all oncologic specialties, including, but not limited to, the following areas:

Cancer biology
--------------

Molecular biology • cellular biology • molecular genetics • genomics • immunology • epigenetics • metabolic studies • proteomics • cytopathology • carcinogenesis • drug discovery and delivery

Clinical cancer research
------------------------

Translational research • clinical trials • chemotherapy • radiation therapy • surgical therapy • clinical observations • clinical guidelines • genetic consultation • ethical considerations

Cancer prevention
-----------------

Behavioral science • psychosocial studies • screening • nutrition • epidemiology and prevention • community outreach

*Cancer Medicine* publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.

We aim to be a truly global forum for high-quality cancer research, and we think that the best research should be published and made widely accessible as quickly as possible. *Cancer Medicine* publishes papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley-Blackwell.

*Cancer Medicine* is a Wiley Open Access journal, one of a new series of peer-reviewed titles publishing quality research with speed and efficiency. For further information visit the Wiley Open Access website at <http://www.wileyopenaccess.com>.

Open Access and Copyright
=========================

All articles published by *Cancer Medicine* are fully open access: immediately freely available to read, download and share. All articles accepted from 14 August 2012 are published under the terms of the Creative Commons Attribution License. All articles accepted before this date were published under a Creative Commons Attribution Non-Commercial License. The Creative Commons Attribution License permits use, distribution and reproduction in any medium, provided the original work is properly cited and allows the commercial use of published articles. Copyright on any research article in a journal published by *Cancer Medicine* is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information about open access license and copyright can be found at <http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html>.

Purchasing Print Reprints
=========================

Print reprints of Wiley Open Access articles can be purchased from <corporatesales@wiley.com>.

Disclaimer
==========

The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher and Editors, neither does the publication of advertisements constitute any endorsements by the Publisher and Editors of the products advertised.

Wiley Open Access articles posted to repositories or websites are without warranty from Wiley of any kind, either express or implied, including, but not limited to, warranties of merchantability, fitness for a particular purpose, or non-infringement. To the fullest extent permitted by law Wiley disclaims all liability for any loss or damage arising out of, or in connection with, the use of or inability to use the content.
